Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $29.2 million.
- Contineum Therapeutics' Shares Outstanding rose 1339.15% to $29.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year increase of 1339.15%. This contributed to the annual value of $25.9 million for FY2024, which is 6254.35% up from last year.
- Latest data reveals that Contineum Therapeutics reported Shares Outstanding of $29.2 million as of Q3 2025, which was up 1339.15% from $25.9 million recorded in Q2 2025.
- Contineum Therapeutics' 5-year Shares Outstanding high stood at $29.2 million for Q3 2025, and its period low was $11.9 million during Q1 2023.
- Moreover, its 3-year median value for Shares Outstanding was $25.7 million (2024), whereas its average is $21.2 million.
- In the last 5 years, Contineum Therapeutics' Shares Outstanding skyrocketed by 6897.74% in 2024 and then surged by 76.44% in 2025.
- Contineum Therapeutics' Shares Outstanding (Quarter) stood at $15.9 million in 2023, then surged by 62.54% to $25.9 million in 2024, then rose by 12.87% to $29.2 million in 2025.
- Its Shares Outstanding stands at $29.2 million for Q3 2025, versus $25.9 million for Q2 2025 and $25.9 million for Q1 2025.